Author: claimsbot

1. A mounting apparatus comprising:
a base having a first end and a second end, a mounting plate and a faceplate positioned on said mounting plate;
a first support member positioned on said first end of said base, said first support member including a support base and a support rod extending from said support base;
a second support member positioned on said second end of said base, said second support member including a support base having a bore extending therethrough;
a locking bar pivotably secured in said bore of said second support member, said locking bar having a lock, said lock being adapted to be releasably secured to said support rod of said first support member; and
a post pivotably secured to said faceplate of said base between said first and second end of said base, said post being adapted to engage a device to prevent actuation of said device.
2. A mounting apparatus comprising:
a base having a first end and a second end;
a first support member positioned proximate said first end of said base;
a second support member positioned proximate said second end of said base;
a locking bar moveably secured at a first end to said second support member and having at a second end a lock, said lock being adapted to be releasably secured to said first support member;
a post moveably secured to said base between said ends of said base, said post being adapted to engage a switch of a device positioned in said apparatus to prevent actuation of said device;
said base comprising a mounting plate and a faceplate, said mounting plate comprising an upper surface having a pair of ends, each end of said upper surface having a U-shaped opening defined therein; and
said faceplate comprising a top surface having a pair of ends, each end of said top surface of said faceplate having a U-shaped opening defined therein.
3. The apparatus of claim 2, wherein said first support member comprises a base and a support rod extending from said base, said base of said support member being adapted to engage an end of said base of said apparatus.
4. A mounting apparatus comprising:
a base having a first end and a second end;
a first support member positioned proximate said first end of said base;
a second support member positioned proximate said second end of said base;
a locking bar moveably secured at a first end to said second support member and having at a second end a lock, said lock being adapted to be releasably secured to said first support member; and
a post moveably secured to said base between said ends of said base, said post being adapted to engage a switch of a device positioned in said apparatus to prevent actuation of said device; and
said first support member comprising a conical base and a support rod extending from said base, said base of said support member being adapted to engage an end of said base of said apparatus.
5. The apparatus of claim 4, wherein conical base further comprises a flange positioned on an upper portion of said conical base and a circumferentially extending groove.
6. A mounting apparatus comprising:
a base having a first end and a second end;
a first support member positioned proximate said first end of said base;
a second support member positioned proximate said second end of said base;
a locking bar moveably secured at a first end to said second support member and having at a second end a lock, said lock being adapted to be releasably secured to said first support member; and
a post moveably secured to said base between said ends of said base, said post being adapted to engage a switch of a device positioned in said apparatus to prevent actuation of said device;
said first support member comprises a base and a support rod extending from said base, said base of said support member being adapted to engage an end of said base of said apparatus; and
a sleeve positioned around said support rod.
7. The apparatus of claim 6, wherein said support rod has a lock head disposed on an end opposite said base of said first support member.
8. The apparatus of claim 6, wherein sleeve has a flared end portion and a flange is positioned on said first support member, said flared end portion of said sleeve being secured to said flange.
9. A mounting apparatus comprising:
a base having a first end and a second end;
a first support member positioned proximate said first end of said base;
a second support member positioned proximate said second end of said base;
a locking bar moveably secured at a first end to said second support member and having at a second end a lock, said lock being adapted to be releasably secured to said first support member; and
a post moveably secured to said base between said ends of said base, said post being adapted to engage a switch of a device positioned in said apparatus to prevent actuation of said device;
said second support member comprising a base; and
said base having a longitudinally extending axial base extending therethrough and being adapted to engage an end of said base of said apparatus.
10. The apparatus of claim 9, wherein said base of said second support member comprises a conical base.
11. The apparatus of claim 9, wherein said second support member further comprising a sleeve positioned around said locking bar and being secured to said base.
12. A mounting apparatus comprising:
a base having a first end and a second end;
a first support member positioned proximate said first end of said base;
a second support member positioned proximate said second end of said base;
a locking bar moveably secured at a first end to said second support member and having at a second end a lock, said lock being adapted to be releasably secured to said first support member; and
a post moveably secured to said base between said ends of said base, said post being adapted to engage a switch of a device positioned in said apparatus to prevent actuation of said device; and
a pivot plate pivotably secured to said base, said post extending from said pivot plate.
13. The apparatus of claim 12, wherein said pivot plate comprises a disk.
14. The apparatus of claim 12, wherein said pivot plate comprises a crossbar.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

We claim:

1. A process to produce a molded compound which comprises
(1) mixing
(A) an unsaturated polymer resin which has been synthesized from a natural triglyceride oil containing an effective amount of acid groups in order to thicken with metal ions,
(B) a polymerizable monomer,
(C) a thickening agent to form a polymerizable material,

(2) polymerizing said polymerizable material in a mold to form a molded compound.
2. The process as claimed in clam 1, wherein the polymerization is initiated with an initiator.
3. The process as claimed in claim 1, wherein the mixing step further requires
(D) at least one reinforcing filler or fiber or
(E) at least one internal mold release agent or a mixture of said (D) and said (E).
4. The process as claimed in claim 1, wherein said unsaturated polymer resin is a polyester resin which has been synthesized from a triglyceride oil is produced by at least one of the following steps:
(a) reacting an acrylic acid with an epoxy functional triglyceride oil,
(b) modifying the product produced from step (a) with reactive difunctional molecules or
(c) reacting an unsaturated anhydride with a hydroxy functional triglyceride oil.
5. The process as claimed in claim 1, wherein said unsaturated polymer resin has been synthesized from a triglyceride oil is produced by at least one of the following steps:
(a) reacting an acrylic acid with an epoxy functional triglyceride oil,
(b) modifying of the product produced from step (a) with maleic anhydride acid and phthalic anhydride or
(c) reacting an unsaturated anhydride with a hydroxy functional triglyceride oil.
6. The process as claimed in claim 1, wherein said polymerizable monomer is a compound having at least one unsaturated double bond in the molecule.
7. The process as clamed in claim 1, wherein said polymerizable monomer is a monovinyl compound.
8. The process as clamed in claim 7, wherein said monovinyl compound is styrene, methyl styrene, divinyl benzene or methyl methacrylate.
9. The process as clamed in claim 7, wherein said polymerizable monomer is styrene.
10. The process as clamed in claim 7, wherein amount of monovinyl compound is from about 10 percent by weight to about 75 percent by weight of the triglyceride.
11. The process as claimed in claim 2, wherein said initiator is t-butyl peroxybenzoate or methyl ethyl ketone peroxide.
12. The process as claimed in claim 1, wherein the polymerizing step further requires an inhibitor or an accelerator or a mixture thereof.
13. The process as claimed in claim 12, wherein said inhibitor is quinone.
14. The process as claimed in claim 12, wherein said inhibitor is hydroquinone, p-benzoquinone and toluquinone.
15. The process as claimed in claim 12, wherein said inhibitor is hydroquinone.
16. The process as claimed in claim 12, wherein said accelerator is cobalt naphthenate or cobalt octoate.
17. The process as claimed in claim 1, wherein said thickening agent is magnesium oxide, magnesium hydroxide, calcium oxide, polyaromatic polydiisocyanate or tolylene diisocyanate.
18. The process as claimed in claim 2, wherein said thickening agent is magnesium oxide, polyaromatic polydiisocyanate or tolylene diisocyanate.
19. The process as clamed in claim 1, wherein said triglyceride oil is from soybean oil, linseed oil, rapeseed oil, cottonseed oil, corn oil, rapeseed oil, palm oil, fish oil, canola oil, sunflower oil, safflower oil or peanut oil.
20. The process as claimed in claim 3, wherein said mold release agent is zinc stearate.
21. The process as clamed in claim 1, wherein said polymerizing is accomplished by photon radiation, electron beam radiation, gamma radiation, heat or free radical polymerization.
22. The process as clamed in claim 2, wherein said polymerizing is accomplished by free radical polymerization and said initiator is added to the compound to initiate final cure in the mold and said initiator is a peroxide.
23. The process as clamed in claim 22, wherein said peroxide is benzyl peroxide, methyl ethyl ketone peroxide, hydrogen peroxide or cumene hydroperoxide.
24. The process as clamed in claim 3, wherein said at least one reinforcing filler or fiber is chopped glass fiber, chopped carbon fiber, flax, jute, straw, kenaf, hemp, calcium carbonate, chalk, limestone, silicate, aluminum trihydrate or talc.
25. A molded article prepared by the process of claim 1.
26. A molded composition which consists essentially of
a. an unsaturated polyester resin based which has been synthesized from a predominately natural triglyceride oil containing an effective amount of acid groups in order to thicken with metal ions,
b. a polymerizable monomer and
c. a thickening agent.
27. The composition as claimed in claim 26, which further contains an initiator.
28. The composition as claimed in claim 27, which further contains
at least one reinforcing filler or fiber andor
at least one internal mold release agent.
29. The composition as claimed in claim 27, wherein the polymerizable monomer is styrene.
30. The composition as claimed in claim 27, wherein said initiator is t-butyl peroxybenzoate or methyl ethyl ketone peroxide.
31. The composition as claimed in claim 26, which further contains an inhibitor or an accelerator or a mixture thereof.
32. The composition as claimed in claim 31, which contains said accelerator and wherein said accelerator is cobalt naphthenate or cobalt octoate.
33. The composition as claimed in claim 31, which contains said inhibitor and wherein said inhibitor is p-benzoquinone or hydroquinone.
34. The composition as claimed in claim 26, wherein said thickening agent is magnesium oxide.
35. The composition as claimed in claim 28, wherein said mold release agent is zinc stearate.
36. The composition as claimed in claim 26, wherein said unsaturated polyester resin contains no or substantially no petroleum derived raw materials.

1. A method for generating XML (Extensible Markup Language) parsers through compilation of XML Schema grammars, the method comprising:
parsing an input document with a generated parser, where the generated parser is generated by a three-stage compilation of an XML Schema, where in a first stage the XML Schema is read and modeled in terms of abstract schema components, where in a second stage the XML Schema is augmented with a set of calculated schema components and properties used to drive code generation, and where in a third stage the XML Schema is traversed to generate validation code for each of a collection of elements;
wherein the validation code for ambiguous but legal content models is generated by:
calculating prohibited occurrence ranges for each of the plurality of particles involved;
generating code to:
evaluate each of the plurality of particles in an inner loop conditioned on an effective upper bound;
then, once the inner loop terminates, check forbidden occurrence ranges for an inner particle, and calculate a range of possible repetitions of an outer particle; and
once an outer loop terminates, check a range of total possible repetitions of the outer particle against actual occurrence limits of the outer particle.
2. The method of claim 1, wherein the XML Schema includes either one of: complex types, simple types or a combination of simple types and complex types.
3. The method of claim 1, wherein the XML Schema specifies content models.
4. The method of claim 1, wherein the generated parser is divided into two logical layers, one a scanning layer and the other a validation layer.
5. The method of claim 4, wherein the validation layer is a generated recursive-descent parser that drives a scanner by utilizing compiled, predictive knowledge from the XML Schema.
6. The method of claim 4, wherein the scanning layer includes a set of fixed XML primitives for scanning content at a byte level.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

What is claimed is:

1. A method for the volumetric distribution of a pharmaceutical agent in the tissue of a living vertebrate host, said method comprising:
positioning a needle through the wall of a target blood vessel so that an aperture of the needle is positioned beyond an external elastic lamina (EEL) of the wall by a distance not exceeding 5 mm; and
delivering an amount of the pharmaceutical agent from the aperture so that the agent distributes both longitudinally and radially from the injection site.
2. A method as set in claim 1, wherein the agent distributes longitudinally along the blood vessel over a distance of at least 1 cm and radially by a distance of at least 1 cm or within a time period no greater than 60 minutes.
3. A method as in claim 2, wherein the concentrations of agent at all locations spaced at least 2 cm from the delivery site are at least 10 of the concentration at the delivery site.
4. A method as in claim 1, wherein the agent distributes via the lymphatic system surrounding the target.
5. A method as in claim 1, wherein the aperture of the needle is positioned at a distance less than 5 mm beyond the EEL.
6. A method as in claim 5, wherein pharmaceutical agent comprises a small molecule drug, a protein, or a gene.
7. A method as in claim 6, wherein the agent has a maximum dimension of 200 nm or below.
8. A method as in claim 1, wherein the blood vessel is a coronary blood vessel.
9. A method as in claim 6, wherein the coronary blood vessel is an artery.
10. A method as in claim 7, wherein the coronary artery is at risk of hyperplasia.
11. A method as in claim 7, wherein the coronary artery has regions of vulnerable plaque.
12. A method as in claim 1, wherein the patient is suffering from congestive heart failure or a cardiac arrhythmia.
13. A method as in claim 1, wherein the blood vessel is a cerebral blood vessel and the tissue is in the brain of the host.
14. A method as in claim 1, wherein the blood vessel is a hepatic blood vessel and the tissue is in the liver of the host.
15. A method as in claim 1, wherein the agent is being delivered to treat a neoplastic disease in the tissue.
16. A method as in claim 1, further comprising:
confirming that the aperture is positioned beyond the EEL before delivering the amount of pharmaceutical agent.
17. An improved method for injecting a pharmaceutical agent into the tissue of a living host using a needle positioned from a lumen of a blood vessel, wherein the improvement comprises positioning the needle outwardly from the blood vessel lumen and confirming that a delivery aperture of the needle has penetrated into tissue beyond an external elastic lamina (EEL) of the blood vessel before injecting the pharmaceutical agent.
18. An improved method as in claim 17, wherein confirming comprises injecting contrast media through the needle aperture and observing distribution of the media.
19. An improved method as in claim 17, wherein confirming comprises monitoring injection pressure.
20. An improved method as in claim 17, wherein confirming comprises monitoring temperature near the delivery aperture.
21. An improved method as in claim 17, wherein confirming comprises monitoring pH near he delivery aperture.
22. An improved method as in claim 17, wherein confirming comprises monitoring electrical impedance near the delivery aperture.
23. An improved method as in claim 17, wherein confirming comprises monitoring insertion force while positioning the needle through the EEL.
24. A catheter comprising:
a catheter body;
a needle having an aperture and being deployable from the catheter body; and
means coupled to the needle for detecting when the aperture of the needle has advanced beyond the external elastic lamina of the blood vessel.
25. A catheter as in claim 24, wherein the detecting means comprises a temperature sensor attached to the needle near the aperture.
26. A catheter as in claim 24, wherein the detecting means comprises an electrical impedance sensor attached to the needle near the aperture.
27. A catheter as in claim 24, wherein the detecting means comprises a pH sensor attached to the needle near the aperture.
28. A catheter as in claim 24, wherein the detecting means comprises an insertion force sensor coupled to the needle.
29. A kit for delivering a pharmaceutical agent to a patient suffering from or at risk of vascular disease, said kit comprising:
a catheter having a needle which can be advanced from a blood vessel lumen through a wall of the blood vessel to position an aperture of the needle beyond an external elastic lamina (EEL) of the wall by a distance not exceeding 5 mm; and
instructions for use setting forth a method comprising:
positioning the needle through the wall of the target blood vessel so that the aperture of the needle is positioned beyond the external elastic lamina (EEL) of the wall by a distance not exceeding 5 mm; and
delivering an amount of the pharmaceutical agent from the aperture so that the agent distributes both longitudinally and radially from the injection site.